Master of Business Administration (MBA) 

2010 University of South Carolina Moore Business School - Columbia, South Carolina National Rankings:  No. 1  undergraduate international business program for 18 consecutive years.  No. 1 MBA program for international business, and among the top three International MBA programs for 25 consecutive years.  No. 1 Professional MBA program in South Carolina.

Doctor of Medicine (M.D.) 

2000 Honors Medical School at The Central America Health Sciences University (CAHSU), Belize Medical College. School of Medicine awards the MD degree with an honors distinction to Dr. Charles Richardson who perform original, hypothesis-driven research that demonstrates exceptional ability and knowledge in a Cardiology and Neurology specialty area.  The University is located in Belize City, Belize. 

Bachelor of Science in Chemistry   

1996 Winston-Salem State University Honors Bachelor of Science in Chemistry and Psychology delivers education through high-quality instruction and research. Winston-Salem, North Carolina.

Honors and Awards

Cleveland Clinic Innovation Award 2010

Cleveland Clinic Partnership TransWorld Medical Devices 2007

BioMed Award for Innovation Award 2009

Secrest Healthcare Innovation Award 2007 

Academic Dean’s List

·         Semester GPA in top 1% of 3rd and 4th medical school class years


·         Fundraising Award from the America Heart Association

Advanced Pharmacy Gene Therapy

Texas CRO, LLC

The rapid pace of scientific advances is enabling a greater understanding of diseases at the molecular level. In turn, scientific, technical, and regulatory challenges related to drug development create complexities as companies often focus their R&D where the science is difficult and the failure risks are higher. As a result, the process for researching and developing new medicines is growing in difficulty and length. On average, it takes at least ten years for a new medicine to complete the journey from initial discovery to the marketplace, with clinical trials alone taking six to seven years on average. The average cost to research and develop each successful drug is estimated to be $2.6 billion. This number incorporates the cost of failures – of the thousands and sometimes millions of compounds that may be screened and assessed early in the R&D process, only a few of which will ultimately receive approval. The overall probability of clinical success (the likelihood that a drug entering clinical testing will eventually be approved) is estimated to be less than 12%. While these numbers are daunting, a deeper understanding of the rigorous R&D process can explain why so many compounds do not make it and why it takes such a large, lengthy effort to get a new medicine to patients. Success requires immense resources — the best scientific minds, highly sophisticated technologies, ever-evolving manufacturing processes, and complex project management. It also takes persistence and, sometimes, luck. Ultimately, though, the process of drug discovery brings hope and relief to millions of patients.